Tenaya Therapeutics, Inc.
TNYA
$0.73
-$0.01-1.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 78.09M | 80.89M | 100.55M | 56.31M | 71.67M |
| Total Receivables | 371.00K | 10.63M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.49M | 5.02M | 4.01M | 3.94M | 3.99M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.07M | 25.00K | 1.03M | 990.00K | 218.00K |
| Total Current Assets | 86.01M | 96.56M | 105.59M | 61.24M | 75.88M |
|
|
|||||
| Total Current Assets | 86.01M | 96.56M | 105.59M | 61.24M | 75.88M |
| Net Property, Plant & Equipment | 5.46M | 34.72M | 37.09M | 39.50M | 41.97M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.07M | 3.79M | 4.25M | 4.24M | 4.31M |
| Total Assets | 93.54M | 135.07M | 146.92M | 104.98M | 122.15M |
|
|
|||||
| Total Accounts Payable | 2.90M | 1.91M | 3.58M | 2.84M | 3.30M |
| Total Accrued Expenses | 6.66M | 5.17M | 8.38M | 7.11M | 5.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.88M | 3.12M | 3.02M | 2.93M | 2.83M |
| Total Finance Division Other Current Liabilities | 6.58M | 6.58M | 453.00K | 335.00K | 657.00K |
| Total Other Current Liabilities | 6.58M | 6.58M | 453.00K | 335.00K | 657.00K |
| Total Current Liabilities | 19.02M | 16.78M | 15.44M | 13.21M | 12.65M |
|
|
|||||
| Total Current Liabilities | 19.02M | 16.78M | 15.44M | 13.21M | 12.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.07M | 7.00M | 7.81M | 8.60M | 9.38M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.04M | 5.10M | 410.00K | 301.00K | 293.00K |
| Total Liabilities | 24.13M | 28.88M | 23.66M | 22.11M | 22.32M |
|
|
|||||
| Common Stock & APIC | 737.08M | 730.47M | 728.27M | 667.70M | 664.39M |
| Retained Earnings | -667.67M | -624.28M | -605.01M | -584.83M | -564.56M |
| Treasury Stock & Other | -- | -- | -- | -- | -1.00K |
| Total Common Equity | 69.41M | 106.19M | 123.27M | 82.87M | 99.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 69.41M | 106.19M | 123.27M | 82.87M | 99.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 69.41M | 106.19M | 123.27M | 82.87M | 99.83M |
|
|
|||||